ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.98
0.86%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.44482
-0.19%
Bitcoin
108,821.24
5.57%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) News

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTYX
DateTimeSourceHeadlineSymbolCompany
01/14/20258:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
01/14/20257:00AMGlobeNewswire Inc.Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor PortfolioNASDAQ:VTYXVentyx Biosciences Inc
01/03/20255:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
01/03/20255:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
01/03/20255:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
01/03/20255:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
12/30/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
12/27/20243:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
12/19/20245:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
12/19/20245:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
12/19/20245:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
12/11/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
11/25/20248:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
11/17/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VTYXVentyx Biosciences Inc
11/15/20243:59PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VTYXVentyx Biosciences Inc
11/07/20244:13PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VTYXVentyx Biosciences Inc
11/07/20243:58PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
11/07/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
11/07/20243:05PMGlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
10/15/20247:00AMGlobeNewswire Inc.Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024NASDAQ:VTYXVentyx Biosciences Inc
09/30/20243:40PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTYXVentyx Biosciences Inc
09/23/20247:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
09/23/20247:00AMGlobeNewswire Inc.Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiNASDAQ:VTYXVentyx Biosciences Inc
09/09/20243:47PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
09/06/20247:00AMGlobeNewswire Inc.Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
08/30/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
08/30/20247:00AMGlobeNewswire Inc.Ventyx Biosciences Announces Departure of Chief Financial OfficerNASDAQ:VTYXVentyx Biosciences Inc
08/28/20247:00AMGlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
08/13/20243:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
08/13/20243:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

Your Recent History

USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
WDLF
Decentral Life (PK)
COIN
XRPUSD
Ripple
NASDAQ
ILLR
Triller
USOTC
XERI
Xeriant (QB)
USOTC
RNVA
Rennova Health (CE)
USOTC
RDGL
Vivos (QB)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
LWLG
Lightwave Logic
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RDAR
Raadr (PK)
NASDAQ
COOP
Mr Cooper
USOTC
TWOH
Two Hands (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads